Speaker illustration

Doctor Manan Pareek

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

Member of:

European Society of Cardiology

Dr. Manan Pareek is an MD, PhD, FAHA, FESC, currently working as a resident in internal medicine. He has co-supervised 5 masters theses and co-mentored 5 PhD-students. He has almost 20 years of teaching experience. Dr. Pareek has been a volunteer member of the Danish Society of Cardiology since 2014 where he has authored or co-authored >20 guidelines and been on the endorsement committees for two ESC guidelines (dual antiplatelet therapy and hypertension). He is currently the chair of the Danish Working Group for Acute Coronary Syndromes and a nucleus member in the Working Group for Thrombosis. He has worked with hypertension, biomarkers, antiplatelet drugs, prediction of diabetes, cardiovascular disease, and mortality, and is the principal investigator of ASPRIN-C3 (NCT05932472). Finally, Dr. Pareek serves as a peer reviewer for >40 journals and has reviewed abstracts for the American Heart Association and ESC since 2018. He has authored or co-authored >135 peer-reviewed articles.

High-sensitivity troponin T and risk of stroke in persons with suspected acute coronary syndrome

Event: ESC Congress 2024

Topic: Biomarkers

Session: Diagnostic and prognostic performance of cardiac troponin

Thumbnail

Body mass index and clinical outcomes in patients with diabetes and stable coronary artery disease in THEMIS

Event: ESC Congress 2024

Topic: Antiplatelet Drugs

Session: Diabetes, obesity, and the heart

Thumbnail

High-sensitivity troponin-T concentrations and long-term risk of death in patients with acute pulmonary embolism

Event: ESC Congress 2023

Topic: Pulmonary Embolism (PE)

Session: Risk assessment, biomarkers, treatments of acute pulmonary embolism: are we able to impact outcomes?

Thumbnail

Serial high-sensitivity troponin-I and long-term risk of myocardial infarction and coronary revascularization in subjects with suspected acute coronary syndrome

Event: ESC Congress 2023

Topic: Biomarkers

Session: Risk stratification in acute coronary syndromes (1)

Thumbnail

Blood pressure and clinical outcomes in patients with diabetes and stable coronary artery disease in THEMIS

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Coronary artery disease - Pharmacotherapy 1

Thumbnail

Serial high-sensitivity troponin T concentrations and long-term outcomes in patients with suspected acute coronary syndrome

Event: ESC Congress 2022

Topic: Biomarkers

Session: Biomarkers and more

Thumbnail

Greater event rates in high-risk patients with a history of heart disease: from the Systolic Blood Pressure Intervention Trial (SPRINT)

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Hypertension e-posters

Thumbnail

Marital status, cardiovascular events, and intensive blood pressure lowering among men and women in the Systolic Blood Pressure Intervention Trial

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Hypertension e-posters

Thumbnail

YNHHS-COVID-19 - Cardiac Complications Registry

Event: ESC Congress 2020

Topic: Epidemiology

Session: COVID and Cardiovascular Disease

Thumbnail

Serial changes in high-sensitivity troponin I levels indicate poorer prognosis in patients with suspected acute coronary syndrome who fail to reach a level greater than the 99th percentile

Event: ESC Congress 2020

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Coronary Syndromes ePosters

Thumbnail